Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Methylation Status of BDNF Gene After Receiving Dialectical Behavior Therapy in Patients With Borderline Personality Disorder

NCT02134223 is registered in ClinicalTrials.gov with Mackay Memorial Hospital as lead sponsor.

NCT NCT02134223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02134223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Methylation Status of BDNF Gene After Receiving Dialectical Behavior Therapy in Patients With Borderline Personality Disorder
Lead sponsor
Mackay Memorial Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2014
Completion date
February 26, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder